Trial Profile
Low Molecular Weight Heparin Versus Aspirin for Venous Thromboembolism Prophylaxis in Orthopaedic Oncology
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Jan 2023
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Enoxaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Therapeutic Use
- 13 Feb 2020 Planned number of patients changed from 2868 to 1434.
- 22 Mar 2018 Status changed from not yet recruiting to recruiting.
- 12 Aug 2017 New trial record